Breaking Finance News

Quest Diagnostics Inc (NYSE:DGX) has been downgraded to Hold in a report by Zacks Investment Research today.

Zacks Investment Research has downgraded Quest Diagnostics Inc (NYSE:DGX) to Hold in a statement released on Monday June 05, 2017.

Having a price of $109.94, Quest Diagnostics Inc (NYSE:DGX) traded 0.52% higher on the day. With the last close up -12.68% from the two hundred day average, compared with the Standard & Poor's 500 Index which has increased 0.03% over the same period. The company has recorded a 50-day moving average of $99.98 and a 200-day moving average of $104.83. 1,064,424 shares of the stock traded hands, down from an average trading volume of 1,071,990

See Chart Below

Quest Diagnostics Inc (NYSE:DGX)

Quest Diagnostics Inc has a 52 week low of $79.12 and a 52 week high of $112.97 with a PE ratio of 18.45 Quest Diagnostics Inc’s market capitalization is currently $0.

In addition to Zacks Investment Research reporting its stock price target, a total of 16 brokerages have issued a research note on the company. The average stock price target is $74.13 with 1 brokerage rating the stock a strong buy, 2 brokerages rating the stock a buy, 17 brokerages rating the stock a hold, 2 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.

Brief Synopsis On Quest Diagnostics Inc (NYSE:DGX)

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.